Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human CD319 (SLAMF7) (Elotuzumab) - 50 mg | Login | Anti-Human CD319 (SLAMF7) (Elotuzumab) - 50 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD319 (SLAMF7) (Elotuzumab) - 5 mg | Login | Anti-Human CD319 (SLAMF7) (Elotuzumab) - 5 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD319 (SLAMF7) (Elotuzumab) - Fc Muted™ - 500 µg | Login | Anti-Human CD319 (SLAMF7) (Elotuzumab) - Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 1.0 mg | Login | Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 1.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 25 mg | Login | Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 5.0 mg | Login | Anti-Human CD79b (Polatuzumab) [Clone RG7596] - 5.0 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD79b (Polatuzumab) [Clone RG7596] — Fc Muted™ - 500 µg | Login | Anti-Human CD79b (Polatuzumab) [Clone RG7596] — Fc Muted™ - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 (Clone 131922) - 25 µg | Login | Anti-Mouse CD4 (Clone 131922) - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 (Clone 131922) - 500 µg | Login | Anti-Mouse CD4 (Clone 131922) - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 (Clone 1C10) - 25 µg | Login | Anti-Mouse CD40 (Clone 1C10) - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 (Clone 1C10) - 100 µg | Login | Anti-Mouse CD40 (Clone 1C10) - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 (Clone 65924) - 25 µg | Login | Anti-Mouse CD40 (Clone 65924) - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 (Clone 65924) - 500 µg | Login | Anti-Mouse CD40 (Clone 65924) - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 - 25 µg | Login | Anti-Mouse CD40 - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40 - 100 µg | Login | Anti-Mouse CD40 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD4 (Clone OKT-4) – Purified - 50 µg | Login | Anti-Human CD4 (Clone OKT-4) – Purified - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD4 (Clone OKT-4) – Purified - 100 µg | Login | Anti-Human CD4 (Clone OKT-4) – Purified - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD4 (Clone OKT-4) – Purified - 200 µg | Login | Anti-Human CD4 (Clone OKT-4) – Purified - 200 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Daxx (CT) - 0.1 mg | Login | Anti-Human Daxx (CT) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R3 (Extracellular Domain-2) - 0.1 mg | Login | Anti-Human TRAIL R3 (Extracellular Domain-2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R4 (Internal Domain) - 0.1 mg | Login | Anti-Human TRAIL R4 (Internal Domain) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CX3CR1 [Clone SA011F11]; Atto 550-RX032 - 25 tests | Login | Anti-Mouse CX3CR1 [Clone SA011F11]; Atto 550-RX032 - 25 tests | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD40-BX045 (3/23); Alexa Fluor™ 647-RX045 - 25 tests | Login | Anti-Mouse CD40-BX045 (3/23); Alexa Fluor™ 647-RX045 - 25 tests | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Daxx (CT) - 20 µg | Login | Anti-Human Daxx (CT) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R3 (Extracellular Domain-2) - 20 µg | Login | Anti-Human TRAIL R3 (Extracellular Domain-2) - 20 µg | ||||||||||||||||
|
||||||||||||||||||


